US 6207690
Troglitazone compounds for treating climacteric and cancer
expired A61KA61K31/426A61K31/427
Quick answer
US patent 6207690 (Troglitazone compounds for treating climacteric and cancer) held by The Board of Regents of the University of Texas System expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Mar 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/426, A61K31/427, A61K31/4439, A61P